By Julie Steenhuysen
CHICAGO (Reuters) - Most depressed adolescents and teenagers who get treatment with drugs, therapy or both will get some relief, but nearly half will relapse within five years, U.S. researchers said on Monday.
And females are by far at greatest risk, they said.
"We need to learn why females in this age range have higher chances of descending into another major depression after they have made a recovery," Dr. John Curry of Duke University in North Carolina, whose study appeared online yesterday in the Archives of General Psychiatry, said in a statement.
Curry and colleagues studied 86 depressed males and 110 depressed females aged 12 to 17 who were assigned to one of four short-term treatments: fluoxetine (Prozac), cognitive behavioral therapy, a combination of the two, or a placebo.
They were followed for up for five years.
Nearly 95% of participants recovered from their initial bout of depression, including 88.3% who recovered within two years.
But of the 189 teenagers who recovered, 88, or 46.6%, had another major depression over the five-year period.
They said being female was the biggest factor that predicted a relapse in the study, with 57% of females having a relapse, compared with just 33% of males.
Dr. Curry said it is not clear why females have a greater risk, but it may be that they are more inclined to repeatedly ruminate on negative thoughts or feelings of inadequacy.
Although females are more likely to become depressed than males during adulthood as well as adolescence, adult women are not more likely than men to have a second major bout of depression, Dr. Curry said.
"Further research needs to be done to confirm our findings and to sort out the variables that may be associated with recurrent major depression in young women," Dr. Curry said.
The team had thought the type of treatment would play a role in how lasting the recovery was, but that was not the case.
They said no individual treatment or treatment combination reduced the risk of relapse. But they did say teenagers who responded within the first two years were most likely to have a lasting reprieve from their symptoms.
In a separate study published yesterday in Pediatrics, researchers at the University of Washington, Seattle Children's and Group Health said they have developed a patient questionnaire that is a good screening test for depression in adolescents.
The test, known as PHQ-9, is a short, easy to score test that has been proven to spot major depression in adults.
Dr. Laura Richardson tested the screening tool on 442 teens aged 13 to 17 and compared it to a longer, more labor-intensive screening tool called the Child Diagnostic Interview Schedule.
They found the test was highly sensitive in picking out teenagers with depression, and could be useful as a screening tool for primary care doctors.
- Arch Gen Psychiatry 2010
- Pediatrics 2010
Copyright © 2010 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.